943979-38-2

Basic information

• Product Name: (3R,5S,8aR)-3-butyl-5-propyloctahydroindolidine
• CAS NO: 943979-38-2
• Molecular Weight: 223.402
• Mol File: 943979-38-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (3R,5S,8aR)-3-butyl-5-propyloctahydroindolidine(CAS DataBase Reference)
• NIST Chemistry Reference: (3R,5S,8aR)-3-butyl-5-propyloctahydroindolidine(943979-38-2)
• EPA Substance Registry System: (3R,5S,8aR)-3-butyl-5-propyloctahydroindolidine(943979-38-2)

Safety Data

• Hazardous Substances Data: 943979-38-2(Hazardous Substances Data)

Upstream product

• 142841-55-2 (2R,5R)-N-<(benzyloxy)carbonyl>-5-butyl-2-(4-hydroxybutyl)pyrrolidine 
• 142841-56-3 (2R,5R)-N-<(benzyloxy)carbonyl>-5-butyl-2-(4-oxobutyl)pyrrolidine 
• 142841-52-9 (2R,5R)-5-<4-(benzyloxy)butyl>-N-<(benzyloxy)carbonyl>-2-<4-(p-toluenesulfonyloxy)butyl>pyrrolidine 
• 142841-53-0 (2R,5R)-N-<(benzyloxy)carbonyl>-2-<4-(benzoyloxy)butyl>-5-butylpyrrolidine 
• 131618-40-1 (5S,8S)-12-(Benzyloxy)-5,8-bis<(tert-butyldimethylsilyl)oxy>-1-dodecanol 
• 54313-25-6 4-penten-1-yllithium 
• 142841-61-0 (2R,5R)-N-<(benzyloxy)carbonyl>-5-butyl-2-(4-oxoheptyl)pyrrolidine 
• 142841-54-1 (2R,5R)-5-butyl-2-(4-hydroxybutyl)pyrrolidine 
• 214072-11-4 (2R,5R)-1-[(Benzyloxy)carbonyl]-2-butyl-5-(4,5-epoxypentyl)pyrrolidine 
• 134822-19-8 (5S,8S)-1-(benzoyloxy)-12-(benzyloxy)-5,8-bis<(tert-butyldimethylsilyl)oxy>dodecane 
• 134822-26-7 (2R,5R)-2-<4-(benzoyloxy)butyl>-5-<4-(benzyloxy)butyl>-N-<(benzyloxy)carbonyl>pyrrolidine 
• 134822-21-2 (5S,8S)-1-(benzoyloxy)-12-(benzyloxy)-5,8-dodecanediol cyclic sulfate 
• 134822-27-8 (2R,5R)-5-<4-(benzyloxy)butyl>-N-<(benzyloxy)carbonyl>-2-(4-hydroxybutyl)pyrrolidine 
• 134822-20-1 (5S,8S)-1-(benzoyloxy)-12-(benzyloxy)-5,8-dodecanediol 

Relevant articles and documents

Synthesis of indolizidines (-)-195B, (-)-223AB and (-)-239AB: (2S,5R)- l-[(benzyloxy)carbonyl]-2-methoxycarbonyl-5-(4pentenyl)pyrrolidine as a versatile chiral building block

The total syntheses of three levogyre 3,5-disubstituted indolizidines, (-)-195B, (-)-223AB and (-)-239AB are described. The employed strategy is based on the utilization of the common enantiopure trans 2,5-disubstituted pyrrolidine 3, which is assembled b